Daiwa Securities Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.4M Buy
524,385
+155,034
+42% +$8.42M 0.04% 235
2026
Q1
$23.2M Buy
369,351
+14,052
+4% +$1.12M 0.07% 166
2025
Q4
$33.9M Buy
355,299
+36,284
+11% +$3.56M 0.11% 124
2025
Q3
$31.1M Buy
319,015
+47,075
+17% +$4.88M 0.11% 130
2025
Q2
$29.2M Buy
271,940
+26,891
+11% +$2.72M 0.11% 123
2025
Q1
$24.7M Buy
245,049
+35,507
+17% +$3.58M 0.1% 122
2024
Q4
$18.7M Buy
209,542
+12,209
+6% +$1.07M 0.08% 148
2024
Q3
$16.5M Buy
197,333
+15,866
+9% +$1.25M 0.08% 157
2024
Q2
$14M Buy
181,467
+11,184
+7% +$819K 0.07% 157
2024
Q1
$11.7M Buy
170,283
+11,561
+7% +$743K 0.07% 166
2023
Q4
$9.18M Buy
158,722
+7,796
+5% +$416K 0.06% 185
2023
Q3
$7.97M Buy
150,926
+7,613
+5% +$399K 0.06% 185
2023
Q2
$7.75M Buy
143,313
+490
+0.3% +$25.6K 0.05% 195
2023
Q1
$7.14M Buy
142,823
+6,386
+5% +$301K 0.05% 199
2022
Q4
$6.31M Buy
136,437
+4,188
+3% +$181K 0.05% 220
2022
Q3
$5.12M Buy
132,249
+2,784
+2% +$112K 0.04% 237
2022
Q2
$4.83M Sell
129,465
-6
-0% -$244 0.04% 260
2022
Q1
$5.74M Buy
129,471
+5,589
+5% +$242K 0.04% 259
2021
Q4
$5.26M Sell
123,882
-7,461
-6% -$314K 0.03% 275
2021
Q3
$5.7M Buy
131,343
+7,922
+6% +$350K 0.04% 238
2021
Q2
$5.28M Buy
123,421
+3,586
+3% +$151K 0.04% 229
2021
Q1
$4.63M Sell
119,835
-211,109
-64% -$7.99M 0.03% 220
2020
Q4
$11.9M Buy
330,944
+257,907
+353% +$9.3M 0.09% 111
2020
Q3
$2.79M Sell
73,037
-59,951
-45% -$2.31M 0.03% 270
2020
Q2
$2.17M Hold
132,988
0.05% 216
2020
Q1
$4.34M Sell
132,988
-5,769
-4% -$225K 0.05% 178
2019
Q4
$6.28M Sell
138,757
-22,977
-14% -$961K 0.05% 168
2019
Q3
$6.58M Sell
161,734
-10,492
-6% -$445K 0.06% 162
2019
Q2
$7.4M Sell
172,226
-29,314
-15% -$1.13M 0.07% 133
2019
Q1
$7.74M Sell
201,540
-43,478
-18% -$1.66M 0.07% 127
2018
Q4
$8.66M Sell
245,018
-10,606
-4% -$385K 0.08% 117
2018
Q3
$9.84M Sell
255,624
-90,951
-26% -$3.18M 0.08% 125
2018
Q2
$11.3M Sell
346,575
-61,199
-15% -$1.85M 0.09% 110
2018
Q1
$11.1M Buy
407,774
+7,960
+2% +$216K 0.09% 114
2017
Q4
$9.91M Buy
399,814
+333,435
+502% +$9.2M 0.07% 139
2017
Q3
$1.94M Buy
66,379
+582
+0.9% +$16.1K 0.01% 341
2017
Q2
$1.82M Sell
65,797
-26,200
-28% -$695K 0.01% 339
2017
Q1
$2.29M Sell
91,997
-17,400
-16% -$423K 0.01% 323
2016
Q4
$2.37M Sell
109,397
-193,550
-64% -$4.22M 0.02% 255
2016
Q3
$7.21M Sell
302,947
-173,390
-36% -$4.14M 0.04% 135
2016
Q2
$11.1M Buy
476,337
+22,760
+5% +$492K 0.07% 95
2016
Q1
$8.53M Buy
453,577
+353,630
+354% +$6.21M 0.05% 116
2015
Q4
$1.84M Sell
99,947
-14,800
-13% -$265K 0.01% 268
2015
Q3
$1.88M Sell
114,747
-14,100
-11% -$241K 0.01% 264
2015
Q2
$2.28M Buy
128,847
+97,600
+312% +$1.74M 0.02% 279
2015
Q1
$555K Hold
31,247
﹤0.01% 433
2014
Q4
$414K Sell
31,247
-3,400
-10% -$43.5K ﹤0.01% 459
2014
Q3
$409K Hold
34,647
﹤0.01% 445
2014
Q2
$442K Sell
34,647
-3,100
-8% -$40.3K ﹤0.01% 426
2014
Q1
$510K Sell
37,747
-13,361
-26% -$175K ﹤0.01% 382
2013
Q4
$614K Buy
51,108
+11,261
+28% +$133K 0.01% 347
2013
Q3
$468K Hold
39,847
﹤0.01% 397
2013
Q2
$369K Buy
+39,847
New +$338K ﹤0.01% 493

Other funds holding BSX

Daiwa Securities Group's BSX Position: Q2 2026 in Review

Daiwa Securities Group increased its Boston Scientific (BSX) stake by 42% in Q2 2026, buying an estimated $8.42M and bringing the position to 524,385 shares worth $22.4M. The position accounts for 0.04% of the portfolio, ranked #235.

Daiwa Securities Group first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $33.9M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Daiwa Securities Group held 524,385 shares of Boston Scientific worth $22.4M as of Q2 2026.
  • Daiwa Securities Group bought 155,034 Boston Scientific shares in Q2 2026, an estimated $8.42M.
  • Boston Scientific made up 0.04% of Daiwa Securities Group's portfolio in Q2 2026, its #235 holding.
  • Daiwa Securities Group first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Daiwa Securities Group's Boston Scientific position peaked at $33.9M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.